Laker MF - Search Results

1

Lipid and lipoprotein metabolism in familial combined hyperlipidaemia during treatment of sporadic phaeochromocytoma: a case study.

Winocour PH, Masud T, Clark F, Cooper BG, Laker MF, Alberti KG. Winocour PH, et al. Among authors: laker mf. Postgrad Med J. 1992 May;68(799):371-5. doi: 10.1136/pgmj.68.799.371. Postgrad Med J. 1992. PMID: 1630985 Free PMC article.

2

Serum triglyceride and insulin levels are associated with erythrocyte sodium-lithium counter-transport activity in normoglycaemic individuals.

Winocour PH, Thomas TH, Brown L, Laker MF, Wilkinson R, Alberti KG. Winocour PH, et al. Among authors: laker mf. Clin Chim Acta. 1992 Jun 30;208(3):193-203. doi: 10.1016/0009-8981(92)90076-3. Clin Chim Acta. 1992. PMID: 1499138

3

Relation between insulinemia, body mass index, and lipoprotein composition in healthy, nondiabetic men and women.

Winocour PH, Kaluvya S, Ramaiya K, Brown L, Millar JP, Farrer M, Neil HA, Laker MF, Alberti KG. Winocour PH, et al. Among authors: laker mf. Arterioscler Thromb. 1992 Mar;12(3):393-402. doi: 10.1161/01.atv.12.3.393. Arterioscler Thromb. 1992. PMID: 1547196

4

Microalbuminuria and associated cardiovascular risk factors in the community.

Winocour PH, Harland JO, Millar JP, Laker MF, Alberti KG. Winocour PH, et al. Among authors: laker mf. Atherosclerosis. 1992 Mar;93(1-2):71-81. doi: 10.1016/0021-9150(92)90201-q. Atherosclerosis. 1992. PMID: 1596306

5

Relation of lipid peroxides to macrovascular disease in type 2 diabetes.

Velázquez E, Winocour PH, Kesteven P, Alberti KG, Laker MF. Velázquez E, et al. Among authors: laker mf. Diabet Med. 1991 Oct;8(8):752-8. doi: 10.1111/j.1464-5491.1991.tb01695.x. Diabet Med. 1991. PMID: 1838067

6

Drug therapy for diabetic dyslipoproteinaemia: a practical approach.

Winocour PH, Laker MF. Winocour PH, et al. Among authors: laker mf. Diabet Med. 1990 May;7(4):292-8. doi: 10.1111/j.1464-5491.1990.tb01392.x. Diabet Med. 1990. PMID: 2140080 Review. No abstract available.

7

Within-clinic reagent strip lipid measurement.

Neil HA, Cassidy DM, Laker MF, Alberti KG. Neil HA, et al. Among authors: laker mf. Diabet Med. 1989 Dec;6(9):824-8. doi: 10.1111/j.1464-5491.1989.tb01289.x. Diabet Med. 1989. PMID: 2533047

8

The effects of lipid lowering drugs on metabolic control and lipoprotein composition in type 2 diabetic patients with mild hyperlipidaemia.

Stewart MW, Dyer RG, Alberti KG, Laker MF. Stewart MW, et al. Among authors: laker mf. Diabet Med. 1995 Mar;12(3):250-7. doi: 10.1111/j.1464-5491.1995.tb00467.x. Diabet Med. 1995. PMID: 7758262 Clinical Trial.

9

Circulating lipids and glycaemic control in insulin dependent diabetic children.

Azad K, Parkin JM, Court S, Laker MF, Alberti KG. Azad K, et al. Among authors: laker mf. Arch Dis Child. 1994 Aug;71(2):108-13. doi: 10.1136/adc.71.2.108. Arch Dis Child. 1994. PMID: 7944528 Free PMC article.

10

The contribution of lipids to coronary heart disease in diabetes mellitus.

Stewart MW, Laker MF, Alberti KG. Stewart MW, et al. Among authors: laker mf. J Intern Med Suppl. 1994;736:41-6. J Intern Med Suppl. 1994. PMID: 7986307 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters